We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
Cap. Flow
+$418M
Cap. Flow %
0.12%
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199

Sector Composition

Rank Sector Weight
1 Technology 32.82%
2 Financials 13.01%
3 Consumer Discretionary 11.23%
4 Communication Services 9.04%
5 Industrials 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HURA
3226
TuHURA Biosciences
HURA
$134M
$74.9K ﹤0.01%
+33,575
New +$113K
TKNO icon
3227
Alpha Teknova
TKNO
$266M
$69.5K ﹤0.01%
+14,158
New +$83.3K
CHRS icon
3228
Coherus Oncology
CHRS
$217M
$69.5K ﹤0.01%
95,056
OPAL icon
3229
OPAL Fuels
OPAL
$67.1M
$68.9K ﹤0.01%
+28,453
New +$66.1K
NL icon
3230
NLI Holdings
NL
$284M
$64.7K ﹤0.01%
10,105
-13,052
-56% -$98.3K
NXXT
3231
NextNRG Inc
NXXT
$50.7M
$64.4K ﹤0.01%
+23,238
New +$70.9K
ISPR icon
3232
Ispire Technology
ISPR
$89M
$62.6K ﹤0.01%
24,454
CLPR
3233
Clipper Realty
CLPR
$46.5M
$55.5K ﹤0.01%
15,124
-10,462
-41% -$40K
SLND icon
3234
Southland Holdings
SLND
$33.6M
$54.8K ﹤0.01%
13,098
MRDN
3235
Meridian Holdings Inc
MRDN
$168M
$45.1K ﹤0.01%
2,210
INMB icon
3236
INmune Bio
INMB
$43.1M
$38.2K ﹤0.01%
16,518
ELEV
3237
DELISTED
Elevation Oncology
ELEV
$8.78K ﹤0.01%
23,913
-150,224
-86% -$50.1K
ADVWW
3238
DELISTED
Advantage Solutions Warrant
ADVWW
$3.5K ﹤0.01%
10,558
SBT
3239
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$279 ﹤0.01%
27,857
ABOS icon
3240
Acumen Pharmaceuticals
ABOS
$154M
-78,446
Closed -$86.3K
ACHV icon
3241
Achieve Life Sciences
ACHV
$626M
-46,668
Closed -$125K
ACRV icon
3242
Acrivon Therapeutics
ACRV
$68.5M
-13,402
Closed -$27.2K
ADVM
3243
DELISTED
Adverum Biotechnologies
ADVM
-31,847
Closed -$139K
AKYA
3244
DELISTED
Akoya BioSciences
AKYA
-393,183
Closed -$15.9M
ALXO icon
3245
ALX Oncology
ALXO
$273M
-164,790
Closed -$103K
AMPY icon
3246
Amplify Energy
AMPY
$163M
-73,428
Closed -$275K
AMTX icon
3247
Aemetis
AMTX
$119M
-87,881
Closed -$153K
APLT
3248
DELISTED
Applied Therapeutics
APLT
-281,028
Closed -$137K
ASML icon
3249
ASML
ASML
$675B
-2,095
Closed -$1.38M
ATNM icon
3250
Actinium Pharmaceuticals
ATNM
$27M
-148,560
Closed -$239K

Similar funds

Nuveen's Q2 2025 Portfolio in Review

As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
  • Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
  • Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
  • Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
  • Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
  • Nuveen opened 192 new positions and closed 199 in Q2 2025.
  • Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.